iNtRON Biotechnology, Inc. Logo

iNtRON Biotechnology, Inc.

Develops drugs, diagnostics, and reagents for infectious diseases and AMR.

048530 | KO

Overview

Corporate Details

ISIN(s):
KR7048530000
LEI:
Country:
South Korea
Address:
경기도 성남시 중원구 사기막골로 137 중앙인더스피아 5차 701~704호, 성남시

Description

iNtRON Biotechnology, Inc. is a biotechnology company specializing in solutions for infectious diseases. Its core activities are centered on three main pillars: bio-new drugs, molecular diagnostics, and molecular biology reagents. The company's therapeutic pipeline focuses on developing novel treatments for drug-resistant super-bacteria, creating antibiotic alternatives and other bio-active agents to address the challenge of antimicrobial resistance (AMR). In its diagnostics division, iNtRON develops and manufactures detection kits and assays, primarily based on real-time PCR technology, for the rapid identification of infectious organisms. The company also provides a range of molecular reagents for research and has commercialized antibiotic alternative products for the animal health market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-12 00:00
수시공시의무관련사항(공정공시) (2024년(제26기) 사업연도 현금 배당 계획 및 자기주식 소각 계획)
Korean 7.9 KB
2024-12-09 00:00
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 29.1 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.1 MB
2024-10-02 00:00
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 27.7 KB
2024-09-23 00:00
신탁계약에의한취득상황보고서
Korean 32.4 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.1 MB
2024-06-28 00:00
기타시장안내 (업종변경 안내)
Korean 4.7 KB
2024-06-19 00:00
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 26.9 KB
2024-05-14 00:00
분기보고서 (2024.03)
Korean 1.1 MB
2024-04-19 00:00
주식등의대량보유상황보고서(일반)
Korean 81.5 KB
2024-03-21 00:00
정기주주총회결과
Korean 19.9 KB
2024-03-13 00:00
감사보고서제출
Korean 25.5 KB
2024-03-13 00:00
사업보고서 (2023.12)
Korean 495.5 KB
2024-03-06 00:00
주주총회소집공고
Korean 218.7 KB
2024-03-06 00:00
의결권대리행사권유참고서류
Korean 218.2 KB

Automate Your Workflow. Get a real-time feed of all iNtRON Biotechnology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for iNtRON Biotechnology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for iNtRON Biotechnology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.